Woodline Partners LP - Jun 30, 2025 SCHEDULE 13G/A Report for Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS)

Filing Manager: Woodline Partners LP
Reporting Manager: Woodline Partners LP
Security: Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share
Symbol: ALGS
Shares outstanding: 5.29M shares
Disclosed Ownership: 518K shares
Ownership: 9.8%
Form type: SCHEDULE 13G/A
Date filed: 8/14/2025, 11:54 AM
Date of event: Jun 30, 2025
Previous filing: May 15, 2025
Next filing: Nov 14, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Woodline Partners LP	9.8%	518K	518K	0	/s/ Erin Mullen	Erin Mullen, General Counsel & Chief Compliance Officer